CARMEN ESPINOSA: Open Payments
NPI 1154426955 · MIAMI, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$628 in 7 payments from 3 companies in 2025. Trend: 2023 $603 · 2024 $252 · 2025 $628
Food & beverage: $628
| Company | Payments | Amount |
|---|---|---|
| Alkermes, Inc. | 4 | $259 |
| Otsuka America Pharmaceutical, Inc. | 2 | $247 |
| Luye Pharma (USA) Ltd. | 1 | $122 |
Products named: REXULTI, ARISTADA, ERZOFRI EXTENDED-RELEASE, LYBALVI.
Industry payments across FL — which companies pay providers there.
